Regulation of the cdk inhibitor, p27 Regulation des cdk inhibitor, p27
Regulation of the cdk inhibitor, p27 Regulation des cdk inhibitor, p27
批准号:
5224632
负责人:
Professor Dr. Martin Eilers
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
1995
资助国家:
德国
项目状态:
已结题
起止时间:
1994-12-31 至 2001-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The proposal aims at elucidating two aspects of regulation of the cell cycle inhibitor, p27kip1. First, we have identified a nucleoporin, mNup2, which interacts with p27 in a two-hybrid assay and in vitro. Using a loss-of-interaction screen, we have identified a specific point mutant of p27 that fails to interact with Nup2. In vivo, this mutant is not correctly localised in the nucleus but accumulates in the Cytosol. We now want to understand the functional implications of this interaction during the cell cycle. Second, we aim at understanding the negative regulation of p27 by Myc. We have found that Myc-induced inactivation of p27 is mediated by cyclin D2. The promoter of the cyclin D2 gene is repressed by Mad proteins and derepressed by a direct interaction with Myc/Max complexes. We now need to fully understand the role of cyclin D2 in cell cycle control and transformation by Myc.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting MYC-driven hepatocellular carcinoma via Aurora-A ligands
-
批准号:409494652
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
ShRNA Screening and Histopathology
-
批准号:280454646
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Targeting MYC in pancreatic cancer
-
批准号:280452953
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Systematic shRNA screens for the analysis of critical signaling pathways in KRAS-mutant multiple myeloma
-
批准号:242271643
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Myc-dependent apoptosis as a tumor-suppressive mechanism: how do cells discriminate between physiological and oncogenic levels of Myc expression?
-
批准号:244461114
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Systemic shRNA screens and high throughout sequencing to investigate pathway dependence in multiple myeloma
-
批准号:144856378
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Systematic shRNA and siRNA screens to investigate drug resistance in human leukemia
-
批准号:81569355
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Role of Miz1 in the Atr/Chk1 signalling pathway and in Myc-induced apoptosis
-
批准号:5422428
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Rolle des Zink-Finger-Proteins Miz-1 in der Tumorigenese und in der Kontrolle der Proliferation von Keratinozyten und Lymphozyten
-
批准号:5340710
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2001
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
MYCN-dependent Transcription Termination and Stress Resilience of Transcription
-
批准号:438596161
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Multimerization of MYC proteins as oncogenic principle
-
批准号:521472328
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
国内基金
海外基金
登录
查看更多内容
细胞周期蛋白A2(CCNA2)通过CDK2促进三阴性乳腺癌的增殖及迁移
-
批准号:JCZRLH202601137
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
抗LAG3抗体改善免疫微环境逆转CDK4/6抑制剂 耐药的机制研究
-
批准号:JCZRLH202600287
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
姜黄素脂质体协同CDK4/6抑制剂通过ROS/DNA损伤通路阻遏乳腺癌转移的机制研究
-
批准号:JCZRLH202600107
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
环状RNAcircWEE1通过miR-942介导的IGF1和CDK6通路双重调控骨肉瘤顺铂耐药的作用机制研究
-
批准号:2026JJ80942
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚昊立
-
依托单位:
基于力学微环境探讨ERK/CDK5/P-MIEF1轴阻滞AECII分化在肺纤维化中的作用及机制研究
-
批准号:2026JJ60258
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邵敏
-
依托单位:
槐耳联合CDK4/6抑制剂调控Cyclin D1-CDK4/6-Rb通路在乳腺癌中的作用及机制研究
-
批准号:2026JJ82715
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:廖妮
-
依托单位:
基于“去宛陈莝,精生形盛”探讨白芍七物颗粒通过CDK4/6-CCND1/2/3-ATM通路时序调控UC肠黏膜细胞周期与DNA损伤修复的机制研究
-
批准号:2026JJ81083
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨宗亮
-
依托单位:
淫羊藿苷通过介导RASSF1α去甲基化抑制cyclinD1/ CDK4/6通路活化改善肺腺癌代谢-免疫失衡的机制研究
-
批准号:2026JJ81663
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曾赛丽
-
依托单位:
B3GAT3介导CDK4蛋白糖基化修饰促进肝癌细胞衰老抵抗与HCC发生发展的机制与转化研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
BK多瘤病毒通过大T抗原调控CDK1建立移
植肾小管上皮细胞内病毒复制微环境的
机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:陈徐涛
-
依托单位: